Avid Bioservices Inc (CDMO)

[pphmtoolong]

Peregrine is in a stronger position than ever. Speaking as one who has owned shares since the Techniclone days, this is obvious.

Bavituximab has potential market value in the billions. No prior Peregrine program was this valuable.

Bavituximab is more than half way though a Phase III trial in a billion dollar indication - lung cancer.

Bavituximab is in the hands of the premier cancer research institute in the world - Memorial Sloan Kettering.

AstraZeneca is drinking our brand of kool ade. Helping fund a trial of Bavi and one of their drugs.

And on and on.

The disconnect with the share price will be resolved in the next few months. What will trigger the resolution? Can't say. Several possibilities.

Hang in there longs. Our day is coming. Finally.

You know how we can be sure? The bashers are here in unprecedented numbers with endless repetitive posts.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul